Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study

被引：24

作者：

Jo, Christine E. ^{[1
]}

Georgakopoulos, Jorge R. ^{[2
]}

Ladda, Matthew ^{[3
]}

Ighani, Arvin ^{[2
]}

Mufti, Asfandyar ^{[2
]}

Drucker, Aaron M. ^{[2
,4
]}

Piguet, Vincent ^{[2
,4
]}

Yeung, Jensen ^{[2
,4
,5
,6
]}

机构：

[1] Univ Ottawa, Fac Med, Ottawa, ON, Canada

[2] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON, Canada

[3] Univ Toronto, Fac Med, Toronto, ON, Canada

[4] Womens Coll Hosp, Div Dermatol, Dept Med, Toronto, ON, Canada

[5] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[6] Prob Med Res Inc, Waterloo, ON, Canada

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 82卷 / 06期

关键词：

D O I：

10.1016/j.jaad.2020.02.029

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

收藏

页码：1530 / 1532

页数：4

相关论文

共 4 条

[1] Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial [J].

Blauvelt, Andrew ;

de Bruin-Weller, Marjolein ;

Gooderham, Melinda ;

Cather, Jennifer C. ;

Weisman, Jamie ;

Pariser, David ;

Simpson, Eric L. ;

Papp, Kim A. ;

Hong, H. Chih-Ho ;

Rubel, Diana ;

Foley, Peter ;

Prens, Errol ;

Griffiths, Christopher E. M. ;

Etoh, Takafumi ;

Pinto, Pedro Herranz ;

Pujol, Ramon M. ;

Szepietowski, Jacek C. ;

Ettler, Karel ;

Kemeny, Lajos ;

Zhu, Xiaoping ;

Akinlade, Bolanle ;

Hultsch, Thomas ;

Mastey, Vera ;

Gadkari, Abhijit ;

Eckert, Laurent ;

Amin, Nikhil ;

Graham, Neil M. H. ;

Pirozzi, Gianluca ;

Stahl, Neil ;

Yancopoulos, George D. ;

Shumel, Brad .

LANCET, 2017, 389 (10086) :2287-2303

[2] Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series [J].

Ruiz-Villaverde, Ricardo ;

Dominguez-Cruz, Javier ;

Carlos Armario-Hita, Jose ;

Martinez-Pilar, Leandro ;

Alcantara-Luna, Sara ;

Juan Pereyra-Rodriguez, Jose .

DERMATOLOGIC THERAPY, 2019, 32 (04)

[3] Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials [J].

Silverberg, J., I ;

Simpson, E. L. ;

Ardeleanu, M. ;

Thaci, D. ;

Barbarot, S. ;

Bagel, J. ;

Chen, Z. ;

Eckert, L. ;

Chao, J. ;

Korotzer, A. ;

Rizova, E. ;

Rossi, A. B. ;

Lu, Y. ;

Graham, N. M. H. ;

Hultsch, T. ;

Pirozzi, G. ;

Akinlade, B. .

BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (01) :80-87

[4] Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis A Randomized Clinical Trial [J].

Worm, Margitta ;

Simpson, Eric L. ;

Thaci, Diamant ;

Bissonnette, Robert ;

Lacour, Jean-Philippe ;

Beissert, Stefan ;

Kawashima, Makoto ;

Ferrandiz, Carlos ;

Smith, Catherine H. ;

Beck, Lisa A. ;

Chan, Kuo-Chen ;

Chen, Zhen ;

Akinlade, Bolanle ;

Hultsch, Thomas ;

Staudinger, Heribert ;

Gadkari, Abhijit ;

Eckert, Laurent ;

Davis, John D. ;

Rajadhyaksha, Manoj ;

Graham, Neil M. H. ;

Pirozzi, Gianluca ;

Stahl, Neil ;

Yancopoulos, George D. ;

Ardeleanu, Marius .

JAMA DERMATOLOGY, 2020, 156 (02) :131-143